EXHIBIT 99.1
MedImmune, Inc.
Patent Table
Respiratory Syncytial Virus (RSV)
4,800,078 Treatment of respiratory disease caused by RSV using human gamma globulin
5,412,077 Effective antibody titers against respiratory viruses
5,582,827 Immunoglobulin from plasma for treatment of RSV
5,824,307 Synagis & other anti-RSV antibodies and their use in treating or preventing RSV infection
6,565,849 Methods of enhancing activity of vaccines and vaccine compositions
6,656,467 Ultra high affinity neutralizing antibodies
6,818,216 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
6,855,493 Methods of Administration/dosing anti-RSV antibodies for prophylaxis and treatment
6,955,717 Crystals and structure of Synagis Fab
7,083,784 Molecules with extended half-lives, compositions and uses thereof
7,132,100 Stabilized liquid anti-RSV antibody formulations
Ethyol
5,292,497 Improving toxicity profiles in chemotherapy
5,424,471 Process for preparing crystalline forms
5,591,731 Dosage forms of crystalline amifostine
5,804,571 Method for protection from AZT side effects and toxicity
5,824,664 Agents and methods for inhibiting HIV viral and protein expression using compounds that belong to a family which contains amifostine
5,846,958 Methods of stimulating hematopoietic progenitor cells using a compound that belong to a family which contains amifostine
5,906,984 Methods of stimulating hematopoietic progenitor cells using specific compounds, which include amifostine
5,994,409 Methods of treating toxicities associated with chemotherapy, a method of treating a nephrodisorder, and a method of treating xerostomia
6,051,563 Subcutaneous administration, method of protecting against toxicities associated with ionizing radiation
6,127,351 Methods of treating or protecting against toxicities associated with chemotherapy using a specific dosing regime
6,218,377 Methods of treating or protecting against toxicities associated with specific chemotherapy agents, and a method of protecting normal tissue
6,239,119 Methods of treating damaged or infected mucosal tissue using a compounds that belongs to a family which contains amifostine
6,384,259 Stable amorphous amifostine composition and methods for the preparation and use of the same
6,407,278 Stable amorphous amifostine composition and methods for the preparation and use of the same
6,489,312 Novel pharmaceutical formulations comprising aminoalkyl phosphorothioates
6,573,253 Methods of the administration of amifostine and related compounds
6,586,476 Methods for treatment of neuro and nephro disorders and therapeutic toxicities using aminothiol compounds
6,753,323 Topical administration of amifostine and related compounds
6,841,545 Stable amorphous amifostine compositions and methods for the preparation of same
7,053,072 Methods for the administration of amifostine and related compounds
7,105,575 Methods for the treatment of neuro- disorders using aminothiol compounds
7,151,094 Topical administration of amifostine and related compounds
Influenza
5,166,057 Recombinant negative strand RNA viruses
5,578,473 Recombinant negative strand RNA viruses
5,690,937 Temperature sensitive mutants of influenza
5,786,199 Recombinant negative strand RNA viruses and vaccines
5,820,871 Recombinant negative strand RNA virus expression systems and vaccines
5,854,037 Recombinant negative strand RNA viruses
6,001,634 Recombinant negative strand RNA viruses
6,090,391 Recombinant tryptophan mutants of influenza PB2 gene
6,322,967 Recombinant tryptophan mutants of influenza PB2 gene
6,528,064 Recombinant tryptophan mutants of influenza
6,544,785 Helper-free rescue of recombinant negative strand RNA virus
6,649,372 Helper-free rescue of recombinant negative strand RNA virus
6,843,996 Immunogenic composition comprising an influenza virus with a temperature sensitive PB2 mutation
6,887,699 Recombinant negative strand RNA virus expression systems and vaccines
6,951,754 DNA transfection system for the generation of infectious influenza virus
6,974,686 Novel recombinant tryptophan mutant of influenza